CIBC World Market’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
CIBC World Market's DYN Position: Q3 2026 in Review
CIBC World Market increased its Dyne Therapeutics (DYN) stake by 14% in Q3 2026, buying an estimated $240K and bringing the position to 86,243 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #975.
CIBC World Market first reported a position in DYN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.68M in Q2 2026. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- CIBC World Market held 86,243 shares of Dyne Therapeutics worth $1.39M as of Q3 2026.
- CIBC World Market bought 10,460 Dyne Therapeutics shares in Q3 2026, an estimated $240K.
- Dyne Therapeutics made up ﹤0.01% of CIBC World Market's portfolio in Q3 2026, its #975 holding.
- CIBC World Market first reported a position in Dyne Therapeutics in Q4 2025 and has held it in 4 quarters since.
- CIBC World Market's Dyne Therapeutics position peaked at $1.68M in Q2 2026.
- 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on CIBC World Market's 13F filing for Q3 2026, filed 10 Nov 2026.